Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (964) Arrow Down
Filter Results: (964) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (964)
    • People  (2)
    • News  (335)
    • Research  (334)
    • Events  (1)
    • Multimedia  (31)
  • Faculty Publications  (130)

Show Results For

  • All HBS Web  (964)
    • People  (2)
    • News  (335)
    • Research  (334)
    • Events  (1)
    • Multimedia  (31)
  • Faculty Publications  (130)
← Page 10 of 964 Results →
  • 12 Nov 2018
  • News

Precision Medicine Has Transformed Cancer Treatment. Here’s How to Move It Beyond Oncology

  • October 2023 (Revised April 2024)
  • Case

Veeva Systems: The Next Frontier

By: Satish Tadikonda and William Marks
Born out of a desire to bring technological advances in enterprise software into the healthcare vertical, Peter Gassner and Matt Wallach founded Veeva to bring life sciences companies into the digital age for data management in both the commercial and R&D sectors. Over... View Details
Keywords: Business Model; Governance Compliance; Applications and Software; Growth Management; Expansion; Technology Industry
Citation
Educators
Purchase
Related
Tadikonda, Satish, and William Marks. "Veeva Systems: The Next Frontier." Harvard Business School Case 824-074, October 2023. (Revised April 2024.)
  • June 2004 (Revised November 2004)
  • Case

Acorda Therapeutics: Rebuilding the Spinal Cord

Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic... View Details
Keywords: Decision Making; Science-Based Business; Health Testing and Trials; Business Startups; Product Development; Biotechnology Industry
Citation
Find at Harvard
Related
Enriquez-Cabot, Juan, Jonathan West, Marina Kolesnik, and Fiona Murray. "Acorda Therapeutics: Rebuilding the Spinal Cord." Harvard Business School Case 604-014, June 2004. (Revised November 2004.)
  • 02 Nov 2021
  • News

Harvard Business School Announces 2021-2022 Kaplan Fellows

  • 2020
  • Book

Healthy Buildings: How Indoor Spaces Drive Performance and Productivity

By: Joseph Allen and John D. Macomber
By the time you reach 80, you will have spent 72 years of your life indoors. Like it or not, humans have become an indoor species. This means that the people who design, build, and maintain our buildings can have a major impact on our health.
Ever feel tired... View Details
Keywords: Architecture; Real Estate Development; Air Pollution; Air Quality; Public Health; Productivity Gains; Buildings and Facilities; Health; Pollutants; Performance Productivity; Construction Industry
Citation
Find at Harvard
Purchase
Related
Allen, Joseph, and John D. Macomber. Healthy Buildings: How Indoor Spaces Drive Performance and Productivity. Cambridge, MA: Harvard University Press, 2020.
  • 12 Sep 2023
  • Book

Successful, But Still Feel Empty? A Happiness Scholar and Oprah Have Advice for You

goals, is the backbone of Brooks’ new book with Oprah Winfrey, Build the Life You Want: The Art and Science of Getting Happier. They weave together the best happiness how-tos from social psychology,... View Details
Keywords: by Avery Forman
  • 12 PM – 1 PM EDT, 26 May 2021
  • Virtual Programming

Perspectives in Health: On Biotechnology Capital Strategy and the Future of Therapeutics

HBS Professor Amitabh Chandra will lead a discussion with Katrine Bosley to discuss the explosion of new ideas, capital in Life Sciences and the implications this has on the next generation of therapeutics. This hour-long discussion will include a Q&A for participants... View Details
  • September 2009 (Revised September 2010)
  • Case

Avid Radiopharmaceuticals and Lighthouse Capital Partners

By: Matthew Rhodes-Kropf and Ann Leamon
In fall 2008, a venture lender must decide whether to make a loan to Avid, a small but promising venture-backed life sciences firm. In reviewing her proposal, Cristy Barnes considers the company's characteristics and how they differ from a typical investment. At the... View Details
Keywords: Business Startups; Decision Choices and Conditions; Financial Crisis; Venture Capital; Private Equity; Financing and Loans; Investment; Financial Services Industry; Health Industry
Citation
Educators
Purchase
Related
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals and Lighthouse Capital Partners." Harvard Business School Case 810-054, September 2009. (Revised September 2010.)

    Mitchell Tang

    Mitchell Tang graduated in 2016 from the University of Pennsylvania, where he completed dual-degrees in computational biology and economics as part of the Vagelos Program in Life Sciences and Management (LSM). While at Penn, Mitchell was involved in research at the... View Details

    • 02 Jan 2024
    • What Do You Think?

    Do Boomerang CEOs Get a Bad Rap?

    Kolev, “Boomerang CEOs: What Happens When the CEO Comes Back?,” MIT Sloan Management Review, September 17, 2020, Kenan Institute of Private Enterprise Research Paper No. 19-27, also available at through the Social Science Research Network... View Details
    Keywords: by James Heskett
    • March 2024
    • Supplement

    Miracle Therapeutics (B)

    By: Satish Tadikonda, William Marks and Wendi Yajnik
    Supplements the (A) case. Following on the negotiations detailed in the Miracle Therapeutics (A) case, Beth Sharp and Jennifer Brilliant from Miracle Therapeutics face new challenges with their company's funding and intellectual property (IP) after several missteps.... View Details
    Keywords: Business Startups; Financing and Loans; Intellectual Property; Problems and Challenges; Business or Company Management
    Citation
    Purchase
    Related
    Tadikonda, Satish, William Marks, and Wendi Yajnik. "Miracle Therapeutics (B)." Harvard Business School Supplement 824-044, March 2024.
    • 18 Sep 2013
    • News

    The 10 most influential women in biotech

      Robin J. Ely

      Robin Ely is the Diane Doerge Wilson Professor of Business Administration at Harvard Business School. She conducts research on race and gender relations in organizations with a focus on leadership, identity, and organizational culture change.... View Details

      • January 2013 (Revised September 2013)
      • Case

      Royal DSM: Fighting Hidden Hunger

      By: Rebecca Henderson, Noah Fisher and Mary Shelman
      In 2007 Royal DSM, a leading life science and materials company, entered a partnership with the World Food Programme (WFP) to combat hidden hunger around the world by providing micronutrient solutions. The case investigates the unexpectedly large impact the partnership... View Details
      Keywords: Conflict of Interests; Human Needs; Partners and Partnerships; Global Range; Nutrition; Science-Based Business; Non-Governmental Organizations; Service Industry; Health Industry
      Citation
      Educators
      Purchase
      Related
      Henderson, Rebecca, Noah Fisher, and Mary Shelman. "Royal DSM: Fighting Hidden Hunger." Harvard Business School Case 313-085, January 2013. (Revised September 2013.)

        Malcolm P. Baker

        Malcolm Baker is the Robert G. Kirby Professor of Business Administration at the Harvard Business School, where he teaches the required course in finance and a short immersive program on investing in life sciences.

        His research is in the... View Details

        Keywords: asset management; biotechnology; financial services; high technology; investment banking industry; pharmaceuticals; private equity (LBO funds); shipping; transportation
        • 26 May 2014
        • News

        How to Win the Lottery (Happily)

        • 2011
        • Book

        Getting to Giving: Fundraising the Entrepreneurial Way

        By: Howard H. Stevenson and Shirley M. Spence
        Getting to Giving is based on Stevenson's many years as a donor, fundraiser and entrepreneur. The book offers practical techniques and real life stories, and brings passion and humor to the art and science of asking for money. Topics included in the book... View Details
        Keywords: Fund Raising; Fundraising; Non-profit Management; Strategy; Nonprofit Organizations; Philanthropy and Charitable Giving
        Citation
        Purchase
        Related
        Stevenson, Howard H., and Shirley M. Spence. Getting to Giving: Fundraising the Entrepreneurial Way. Belmont, MA: Timberline LLC, 2011.
        • 11 Mar 2021
        • News

        6 lessons in teamwork leaders can learn from competitive sailing

        • 22 Oct 2019
        • Video

        The 2018-19 Blavatnik Fellows Embark on their Next Ventures

        • 19 Jul 2019
        • Blog Post

        Making a Broader Impact with Multiple Disciplines

        de-risking technical and commercial milestones to obtain product-market fit and unlock long-term growth.  If I had had the opportunity to enroll in the MS/MBA Biotechnology: Life Sciences Program at Harvard,... View Details
        • ←
        • 10
        • 11
        • …
        • 48
        • 49
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.